I have been following Ionis Pharmaceuticals Inc (IONS) for a while now, they are a very exciting Biotech that has traded very poorly for most of 2021. Ionis is a leader in RNA-based therapies and has a large pipeline of late-stage programs – so basically a Biotech lottery ticket.
I already own Merck, so there are some diversification issues – but the stock is cheap given the huge upside – here is the trade:
- Sold: Ten (10) August 20, 2021 Puts
- Strike Price: $35.00
- *Premium Collected: $950.00
If I am forced to buy the 1000 shares, my entry price will be $34.05, almost a 45% discount to Ionis’s Fair Value of $62.00 per share. I feel this trade provided a healthy Margin of Safety.
Unlike most of my investments, Ionis does not pay a dividend – but I would be comfortable holding the company at these prices given the upside.
*Excludes transaction costs.
Leave a Reply